Suppr超能文献

相似文献

3
A Bcr/Abl-independent, Lyn-dependent form of imatinib mesylate (STI-571) resistance is associated with altered expression of Bcl-2.
J Biol Chem. 2004 Aug 13;279(33):34227-39. doi: 10.1074/jbc.M402290200. Epub 2004 Jun 2.
4
Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.
J Natl Cancer Inst. 2008 Jul 2;100(13):926-39. doi: 10.1093/jnci/djn188. Epub 2008 Jun 24.
8
Expression of a Src family kinase in chronic myelogenous leukemia cells induces resistance to imatinib in a kinase-dependent manner.
J Biol Chem. 2010 Jul 9;285(28):21446-57. doi: 10.1074/jbc.M109.090043. Epub 2010 May 7.
10
Synergy between imatinib and mycophenolic acid in inducing apoptosis in cell lines expressing Bcr-Abl.
Blood. 2005 Apr 15;105(8):3270-7. doi: 10.1182/blood-2004-10-3864. Epub 2004 Dec 16.

引用本文的文献

1
The dualistic role of Lyn tyrosine kinase in immune cell signaling: implications for systemic lupus erythematosus.
Front Immunol. 2024 Jun 28;15:1395427. doi: 10.3389/fimmu.2024.1395427. eCollection 2024.
2
DEAD box RNA helicases are pervasive protein kinase interactors and activators.
Genome Res. 2024 Jul 23;34(6):952-966. doi: 10.1101/gr.278264.123.
3
Overcoming Secondary Mutations of Type II Kinase Inhibitors.
J Med Chem. 2024 Jun 27;67(12):9776-9788. doi: 10.1021/acs.jmedchem.3c01629. Epub 2024 Jun 5.
4
Biochemical and structural characterization of an inositol pyrophosphate kinase from a giant virus.
EMBO J. 2024 Feb;43(3):462-480. doi: 10.1038/s44318-023-00005-0. Epub 2024 Jan 12.
5
Profiling of drug resistance in Src kinase at scale uncovers a regulatory network coupling autoinhibition and catalytic domain dynamics.
Cell Chem Biol. 2024 Feb 15;31(2):207-220.e11. doi: 10.1016/j.chembiol.2023.08.005. Epub 2023 Sep 7.
6
Modulation of IRAK enzymes as a therapeutic strategy against SARS-CoV-2 induced cytokine storm.
Clin Exp Med. 2023 Oct;23(6):2909-2923. doi: 10.1007/s10238-023-01064-7. Epub 2023 Apr 15.
7
Landscape of drug-resistance mutations in kinase regulatory hotspots.
Brief Bioinform. 2021 May 20;22(3). doi: 10.1093/bib/bbaa108.
9
Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.
Front Immunol. 2018 Mar 1;9:401. doi: 10.3389/fimmu.2018.00401. eCollection 2018.
10
Discovery of Bivalent Kinase Inhibitors via Enzyme-Templated Fragment Elaboration.
ACS Med Chem Lett. 2015 Jul 13;6(8):898-901. doi: 10.1021/acsmedchemlett.5b00167. eCollection 2015 Aug 13.

本文引用的文献

3
Positive regulation of Itk PH domain function by soluble IP4.
Science. 2007 May 11;316(5826):886-9. doi: 10.1126/science.1138684. Epub 2007 Apr 5.
4
Structural biology contributions to the discovery of drugs to treat chronic myelogenous leukaemia.
Acta Crystallogr D Biol Crystallogr. 2007 Jan;63(Pt 1):80-93. doi: 10.1107/S0907444906047287. Epub 2006 Dec 13.
5
Phosphorylation of the ATP-binding loop directs oncogenicity of drug-resistant BCR-ABL mutants.
Proc Natl Acad Sci U S A. 2006 Dec 19;103(51):19466-71. doi: 10.1073/pnas.0609239103. Epub 2006 Dec 12.
8
Structure of human Fyn kinase domain complexed with staurosporine.
Biochem Biophys Res Commun. 2006 Aug 4;346(3):840-4. doi: 10.1016/j.bbrc.2006.05.212. Epub 2006 Jun 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验